These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 111445)

  • 1. Effect of D-Trp6-LH-RH on the pituitary-gonadal axis during the luteal phase in the baboon.
    Hagino N; Nakamoto O; Kunz Y; Arimura A; Coy DH; Schally AV
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):217-23. PubMed ID: 111445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of LH release with synthetic LH-RH (author's transl)].
    Koyama T
    Nihon Naibunpi Gakkai Zasshi; 1976 Sep; 52(9):881-97. PubMed ID: 828583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM; Thompson IE; Taymor ML
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization of both luteal and pituitary function in baboons with nafarelin, a potent LH-RH agonist.
    Vickery BH; Powell J; Stevens VC
    Int J Fertil; 1988; 33(3):188-93. PubMed ID: 2899565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of TRH on plasma levels of LH, estrogen, and progestin following LH release: in relation to luteinization during the early luteal phase (author's transl)].
    Koyama T; Saito M; Hagino N
    Nihon Naibunpi Gakkai Zasshi; 1977 Feb; 53(2):151-8. PubMed ID: 410671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical effects of D-Trp6-luteinizing hormone-releasing hormone on the hypothalamic-pituitary-gonadal axis in immature female rats.
    Vilchez-Martinez JA; Pedroza E; Arimura A; Schally AV
    Fertil Steril; 1979 Jun; 31(6):677-82. PubMed ID: 376360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6509-12. PubMed ID: 6458815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons.
    Lewis RW; Dowling KJ; Schally AV
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2975-9. PubMed ID: 3157995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of a highly potent antagonist of LH releasing hormone (SB-75) on the pituitary gonadal axis in the intact and castrated rat.
    Ayalon D; Farhi Y; Comaru-Schally AM; Schally AV; Eckstein N; Vagman I; Limor R
    Neuroendocrinology; 1993 Aug; 58(2):153-9. PubMed ID: 8264861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of luteinizing hormone-releasing hormone analogs delays ovulation without affecting the luteal function in rhesus monkeys.
    Borghi MR; Niesvisky R; Balmaceda JP; Coy DH; Schally AV; Asch RH
    Fertil Steril; 1983 Nov; 40(5):678-82. PubMed ID: 6414849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone.
    Torres-Aleman I; Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1252-6. PubMed ID: 2858096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of different LH-RH agonists on the levels of immunoreactive gonadotropins.
    Insler V; Lunenfeld E; Potashnik G; Levy J
    Gynecol Endocrinol; 1988 Dec; 2(4):305-12. PubMed ID: 2976572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of agonistic and antagonistic analogues of LH-RH induce anovulation in Macaca fasicularis.
    Borghi MR; Niesvisky R; Coy DH; Balmaceda JP; Schally AV; Asch RH
    Contraception; 1983 Jun; 27(6):619-26. PubMed ID: 6225623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay for 6-D-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long-acting microcapsule formulations.
    Mason-Garcia M; Vigh S; Comaru-Schally AM; Redding TW; Somogyvari-Vigh A; Horvath J; Schally AV
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1547-51. PubMed ID: 3156381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH.
    Yano T; Korkut E; Pinski J; Szepeshazi K; Milovanovic S; Groot K; Clarke R; Comaru-Schally AM; Schally AV
    Breast Cancer Res Treat; 1992; 21(1):35-45. PubMed ID: 1391973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gonadotrophin releasing hormone baseline concentrations in the control of pituitary gonadotrophin and ovarian steroid secretion in the pseudopregnant rat.
    Schuiling GA; Valkhof N; Koiter TR
    Hum Reprod; 1996 Jan; 11(1):13-8. PubMed ID: 8671150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats.
    Bokser L; Szende B; Schally AV
    Br J Cancer; 1990 Jun; 61(6):861-5. PubMed ID: 2142603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.